glp 1 receptor antagonists Frontiers Evolution of GLP‐1 Receptor Agonists
Description
Hollingshead, B
Death by any cause was 13% lower among patients treated with GLP-1 receptor agonists
However, many health outcomes, like nausea and vomiting, saw their risks increase with GLP-1 use
Before starting, consult with your healthcare provider to determine suitability
Furthermore, tumor necrosis factor- (TNF-) and IL-6 are produced by M1 M, which are relevant components in the occurrence of IR (124)
